| Literature DB >> 24794428 |
Mu Yang1, Rong Mao2,3, Georgia Panagiotakos2,3,4, Thomas Portmann2,3, Jacob Ellegood5, Gul Dolen6, Patrick L Bader3,7, Brad A Grueter3,8, Carleton Goold2,3, Elaine Fisher2,3, Katherine Clifford2,3, Pavitra Rengarajan2,3, David Kalikhman1, Darren Loureiro1, Nay L Saw9, Zhou Zhengqui9, Michael A Miller9, Jason P Lerch5,10, Mark Henkelman5,10, Mehrdad Shamloo3,9,11, Robert C Malenka3,8, Jacqueline N Crawley1, Ricardo E Dolmetsch2,12.
Abstract
A deletion on human chromosome 16p11.2 is associated with autism spectrum disorders. We deleted the syntenic region on mouse chromosome 7F3. MRI and high-throughput single-cell transcriptomics revealed anatomical and cellular abnormalities, particularly in cortex and striatum of juvenile mutant mice (16p11(+/-)). We found elevated numbers of striatal medium spiny neurons (MSNs) expressing the dopamine D2 receptor (Drd2(+)) and fewer dopamine-sensitive (Drd1(+)) neurons in deep layers of cortex. Electrophysiological recordings of Drd2(+) MSN revealed synaptic defects, suggesting abnormal basal ganglia circuitry function in 16p11(+/-) mice. This is further supported by behavioral experiments showing hyperactivity, circling, and deficits in movement control. Strikingly, 16p11(+/-) mice showed a complete lack of habituation reminiscent of what is observed in some autistic individuals. Our findings unveil a fundamental role of genes affected by the 16p11.2 deletion in establishing the basal ganglia circuitry and provide insights in the pathophysiology of autism.Entities:
Mesh:
Year: 2014 PMID: 24794428 PMCID: PMC4251471 DOI: 10.1016/j.celrep.2014.03.036
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423